The right ventricle: the co-star in the complex history of heart failure

The natural history of patients with heart failure (HF), mainly affecting the left ventricle in the initial stages, is marked by the progressive involvement of the right ventricle (RV), which in the advanced stages of the disease becomes dilated and dysfunctional. The geometrical, functional, and pathological interdependence binding the two ventricles underlies this progressive path. Researchers' and clinicians' efforts must be aimed at interrupting the inevitable trajectory of HF, by preventing the development of pulmonary hypertension (PH) and RV dysfunction or the transition from isolated post-capillary PH to combined pre- and post-capillary PH. The search for drugs targeting the pulmonary circulation is another goal of PH researchers. Studies conducted so far on drugs currently approved for patients with pulmonary arterial hypertension have yielded contradictory results; an in-depth analysis of these trials could help researchers profile the patients with HF who might benefit from these treatments.

Authors

Institutions

Publication Details

Journal
European Heart Journal Supplements
Published
2025-02-01
DOI
https://doi.org/10.1093/eurheartjsupp/suae092
Citations
2
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
2.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The right ventricle: the co-star in the complex history of heart failure

Tommaso Recchioni, Domenico Filomena, Roberto Badagliacca, Giovanna Manzi et al.
2 citations
European Heart Journal Supplements
Cardiovascular Function and Risk Factors
2.78
article

The right ventricle: the co-star in the complex history of heart failure

Tommaso Recchioni, Domenico Filomena, Roberto Badagliacca, Giovanna Manzi, Paolo Severino, Alexandra Mihai, Lucia Ilaria Birtolo, Silvia Papa, Carmine Dario Vizza, Massimo Mancone, Andrea D’Amato
article en
2 citations

Abstract

The natural history of patients with heart failure (HF), mainly affecting the left ventricle in the initial stages, is marked by the progressive involvement of the right ventricle (RV), which in the advanced stages of the disease becomes dilated and dysfunctional. The geometrical, functional, and pathological interdependence binding the two ventricles underlies this progressive path. Researchers' and clinicians' efforts must be aimed at interrupting the inevitable trajectory of HF, by preventing the development of pulmonary hypertension (PH) and RV dysfunction or the transition from isolated post-capillary PH to combined pre- and post-capillary PH. The search for drugs targeting the pulmonary circulation is another goal of PH researchers. Studies conducted so far on drugs currently approved for patients with pulmonary arterial hypertension have yielded contradictory results; an in-depth analysis of these trials could help researchers profile the patients with HF who might benefit from these treatments.

European Heart Journal SupplementsVol. 27(Supplement_1)
Policlinico Umberto I (IT), Sapienza University of Rome (IT)
Openalex Percentile: Top 11%
Cardiovascular Function and Risk Factors
2.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The right ventricle: the co-star in the complex history of heart failure — Tommaso Recchioni, Domenico Filomena, et al. · European Heart Journal Supplements (2025) | TGRS Research Map | TGRS